A common menopause treatment does not cause cognitive problems, a study has found.
Researchers conducted a controlled trial of the menopause treatment estradiol/drospirenone.
They found no negative effects on the cognitive function of the women who received the drug.
The findings may put to rest concerns about the safety of the treatment.
Read more at Monash University